Global Brucellosis Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Brucellosis Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Brucellosis Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Brucellosis Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Brucellosis Vaccines Segment by Type

2.2.1 S19 Vaccine

2.2.2 RB51 Vaccine Strain

2.3 Brucellosis Vaccines Sales by Type

2.3.1 Global Brucellosis Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Brucellosis Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Brucellosis Vaccines Sale Price by Type (2017-2022)

2.4 Brucellosis Vaccines Segment by Application

2.4.1 Cattle

2.4.2 Sheep

2.4.3 Others

2.5 Brucellosis Vaccines Sales by Application

2.5.1 Global Brucellosis Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Brucellosis Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Brucellosis Vaccines Sale Price by Application (2017-2022)

3 Global Brucellosis Vaccines by Company

3.1 Global Brucellosis Vaccines Breakdown Data by Company

3.1.1 Global Brucellosis Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Brucellosis Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Brucellosis Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Brucellosis Vaccines Revenue by Company (2020-2022)

3.2.2 Global Brucellosis Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Brucellosis Vaccines Sale Price by Company

3.4 Key Manufacturers Brucellosis Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Brucellosis Vaccines Product Location Distribution

3.4.2 Players Brucellosis Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Brucellosis Vaccines by Geographic Region

4.1 World Historic Brucellosis Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Brucellosis Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Brucellosis Vaccines Annual Revenue by Geographic Region

4.2 World Historic Brucellosis Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Brucellosis Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Brucellosis Vaccines Annual Revenue by Country/Region

4.3 Americas Brucellosis Vaccines Sales Growth

4.4 APAC Brucellosis Vaccines Sales Growth

4.5 Europe Brucellosis Vaccines Sales Growth

4.6 Middle East & Africa Brucellosis Vaccines Sales Growth

5 Americas

5.1 Americas Brucellosis Vaccines Sales by Country

5.1.1 Americas Brucellosis Vaccines Sales by Country (2017-2022)

5.1.2 Americas Brucellosis Vaccines Revenue by Country (2017-2022)

5.2 Americas Brucellosis Vaccines Sales by Type

5.3 Americas Brucellosis Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Brucellosis Vaccines Sales by Region

6.1.1 APAC Brucellosis Vaccines Sales by Region (2017-2022)

6.1.2 APAC Brucellosis Vaccines Revenue by Region (2017-2022)

6.2 APAC Brucellosis Vaccines Sales by Type

6.3 APAC Brucellosis Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Brucellosis Vaccines by Country

7.1.1 Europe Brucellosis Vaccines Sales by Country (2017-2022)

7.1.2 Europe Brucellosis Vaccines Revenue by Country (2017-2022)

7.2 Europe Brucellosis Vaccines Sales by Type

7.3 Europe Brucellosis Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Brucellosis Vaccines by Country

8.1.1 Middle East & Africa Brucellosis Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Brucellosis Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Brucellosis Vaccines Sales by Type

8.3 Middle East & Africa Brucellosis Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Brucellosis Vaccines

10.3 Manufacturing Process Analysis of Brucellosis Vaccines

10.4 Industry Chain Structure of Brucellosis Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Brucellosis Vaccines Distributors

11.3 Brucellosis Vaccines Customer

12 World Forecast Review for Brucellosis Vaccines by Geographic Region

12.1 Global Brucellosis Vaccines Market Size Forecast by Region

12.1.1 Global Brucellosis Vaccines Forecast by Region (2023-2028)

12.1.2 Global Brucellosis Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Brucellosis Vaccines Forecast by Type

12.7 Global Brucellosis Vaccines Forecast by Application

13 Key Players Analysis

13.1 Jinyu

13.1.1 Jinyu Company Information

13.1.2 Jinyu Brucellosis Vaccines Product Offered

13.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Jinyu Main Business Overview

13.1.5 Jinyu Latest Developments

13.2 Colorado Serum

13.2.1 Colorado Serum Company Information

13.2.2 Colorado Serum Brucellosis Vaccines Product Offered

13.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Colorado Serum Main Business Overview

13.2.5 Colorado Serum Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Brucellosis Vaccines Product Offered

13.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Biogenesis-Bago

13.4.1 Biogenesis-Bago Company Information

13.4.2 Biogenesis-Bago Brucellosis Vaccines Product Offered

13.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biogenesis-Bago Main Business Overview

13.4.5 Biogenesis-Bago Latest Developments

13.5 Vetal Company

13.5.1 Vetal Company Company Information

13.5.2 Vetal Company Brucellosis Vaccines Product Offered

13.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Vetal Company Main Business Overview

13.5.5 Vetal Company Latest Developments

13.6 CZ Veterinaria

13.6.1 CZ Veterinaria Company Information

13.6.2 CZ Veterinaria Brucellosis Vaccines Product Offered

13.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 CZ Veterinaria Main Business Overview

13.6.5 CZ Veterinaria Latest Developments

13.7 SYVA Laboratorios

13.7.1 SYVA Laboratorios Company Information

13.7.2 SYVA Laboratorios Brucellosis Vaccines Product Offered

13.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 SYVA Laboratorios Main Business Overview

13.7.5 SYVA Laboratorios Latest Developments

13.8 Indian Immunologicals

13.8.1 Indian Immunologicals Company Information

13.8.2 Indian Immunologicals Brucellosis Vaccines Product Offered

13.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Indian Immunologicals Main Business Overview

13.8.5 Indian Immunologicals Latest Developments

13.9 Qilu

13.9.1 Qilu Company Information

13.9.2 Qilu Brucellosis Vaccines Product Offered

13.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Qilu Main Business Overview

13.9.5 Qilu Latest Developments

13.10 Tecnovax

13.10.1 Tecnovax Company Information

13.10.2 Tecnovax Brucellosis Vaccines Product Offered

13.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Tecnovax Main Business Overview

13.10.5 Tecnovax Latest Developments

13.11 Hester Biosciences

13.11.1 Hester Biosciences Company Information

13.11.2 Hester Biosciences Brucellosis Vaccines Product Offered

13.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Hester Biosciences Main Business Overview

13.11.5 Hester Biosciences Latest Developments

13.12 Zoetis

13.12.1 Zoetis Company Information

13.12.2 Zoetis Brucellosis Vaccines Product Offered

13.12.3 Zoetis Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Zoetis Main Business Overview

13.12.5 Zoetis Latest Developments

13.13 Onderstepoort Biological

13.13.1 Onderstepoort Biological Company Information

13.13.2 Onderstepoort Biological Brucellosis Vaccines Product Offered

13.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Onderstepoort Biological Main Business Overview

13.13.5 Onderstepoort Biological Latest Developments

13.14 Instituto Rosenbusch

13.14.1 Instituto Rosenbusch Company Information

13.14.2 Instituto Rosenbusch Brucellosis Vaccines Product Offered

13.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Instituto Rosenbusch Main Business Overview

13.14.5 Instituto Rosenbusch Latest Developments

13.15 Ceva Sante Animale

13.15.1 Ceva Sante Animale Company Information

13.15.2 Ceva Sante Animale Brucellosis Vaccines Product Offered

13.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Ceva Sante Animale Main Business Overview

13.15.5 Ceva Sante Animale Latest Developments

13.16 Calier & Biologicos Laverlam

13.16.1 Calier & Biologicos Laverlam Company Information

13.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Product Offered

13.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Calier & Biologicos Laverlam Main Business Overview

13.16.5 Calier & Biologicos Laverlam Latest Developments

13.17 Biovet

13.17.1 Biovet Company Information

13.17.2 Biovet Brucellosis Vaccines Product Offered

13.17.3 Biovet Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Biovet Main Business Overview

13.17.5 Biovet Latest Developments

14 Research Findings and Conclusion

Table 1. Brucellosis Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Brucellosis Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of S19 Vaccine

Table 4. Major Players of RB51 Vaccine Strain

Table 5. Global Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)

Table 6. Global Brucellosis Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Brucellosis Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Brucellosis Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Brucellosis Vaccines Sale Price by Type (2017-2022) & (USD/K Doses)

Table 10. Global Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)

Table 11. Global Brucellosis Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Brucellosis Vaccines Revenue by Application (2017-2022)

Table 13. Global Brucellosis Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Brucellosis Vaccines Sale Price by Application (2017-2022) & (USD/K Doses)

Table 15. Global Brucellosis Vaccines Sales by Company (2020-2022) & (M Doses)

Table 16. Global Brucellosis Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Brucellosis Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Brucellosis Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Brucellosis Vaccines Sale Price by Company (2020-2022) & (USD/K Doses)

Table 20. Key Manufacturers Brucellosis Vaccines Producing Area Distribution and Sales Area

Table 21. Players Brucellosis Vaccines Products Offered

Table 22. Brucellosis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Brucellosis Vaccines Sales by Geographic Region (2017-2022) & (M Doses)

Table 26. Global Brucellosis Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Brucellosis Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Brucellosis Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Brucellosis Vaccines Sales by Country/Region (2017-2022) & (M Doses)

Table 30. Global Brucellosis Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Brucellosis Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Brucellosis Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)

Table 34. Americas Brucellosis Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Brucellosis Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Brucellosis Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)

Table 38. Americas Brucellosis Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)

Table 40. Americas Brucellosis Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Brucellosis Vaccines Sales by Region (2017-2022) & (M Doses)

Table 42. APAC Brucellosis Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Brucellosis Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Brucellosis Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)

Table 46. APAC Brucellosis Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)

Table 48. APAC Brucellosis Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)

Table 50. Europe Brucellosis Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Brucellosis Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Brucellosis Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)

Table 54. Europe Brucellosis Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)

Table 56. Europe Brucellosis Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Brucellosis Vaccines Sales by Country (2017-2022) & (M Doses)

Table 58. Middle East & Africa Brucellosis Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Brucellosis Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Brucellosis Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Brucellosis Vaccines Sales by Type (2017-2022) & (M Doses)

Table 62. Middle East & Africa Brucellosis Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Brucellosis Vaccines Sales by Application (2017-2022) & (M Doses)

Table 64. Middle East & Africa Brucellosis Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Brucellosis Vaccines

Table 66. Key Market Challenges & Risks of Brucellosis Vaccines

Table 67. Key Industry Trends of Brucellosis Vaccines

Table 68. Brucellosis Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Brucellosis Vaccines Distributors List

Table 71. Brucellosis Vaccines Customer List

Table 72. Global Brucellosis Vaccines Sales Forecast by Region (2023-2028) & (M Doses)

Table 73. Global Brucellosis Vaccines Sales Market Forecast by Region

Table 74. Global Brucellosis Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Brucellosis Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Brucellosis Vaccines Sales Forecast by Country (2023-2028) & (M Doses)

Table 77. Americas Brucellosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Brucellosis Vaccines Sales Forecast by Region (2023-2028) & (M Doses)

Table 79. APAC Brucellosis Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Brucellosis Vaccines Sales Forecast by Country (2023-2028) & (M Doses)

Table 81. Europe Brucellosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Brucellosis Vaccines Sales Forecast by Country (2023-2028) & (M Doses)

Table 83. Middle East & Africa Brucellosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Brucellosis Vaccines Sales Forecast by Type (2023-2028) & (M Doses)

Table 85. Global Brucellosis Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Brucellosis Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Brucellosis Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Brucellosis Vaccines Sales Forecast by Application (2023-2028) & (M Doses)

Table 89. Global Brucellosis Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Brucellosis Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Brucellosis Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. Jinyu Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. Jinyu Brucellosis Vaccines Product Offered

Table 94. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 95. Jinyu Main Business

Table 96. Jinyu Latest Developments

Table 97. Colorado Serum Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Colorado Serum Brucellosis Vaccines Product Offered

Table 99. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 100. Colorado Serum Main Business

Table 101. Colorado Serum Latest Developments

Table 102. Boehringer Ingelheim Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Boehringer Ingelheim Brucellosis Vaccines Product Offered

Table 104. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 105. Boehringer Ingelheim Main Business

Table 106. Boehringer Ingelheim Latest Developments

Table 107. Biogenesis-Bago Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Biogenesis-Bago Brucellosis Vaccines Product Offered

Table 109. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 110. Biogenesis-Bago Main Business

Table 111. Biogenesis-Bago Latest Developments

Table 112. Vetal Company Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Vetal Company Brucellosis Vaccines Product Offered

Table 114. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 115. Vetal Company Main Business

Table 116. Vetal Company Latest Developments

Table 117. CZ Veterinaria Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. CZ Veterinaria Brucellosis Vaccines Product Offered

Table 119. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 120. CZ Veterinaria Main Business

Table 121. CZ Veterinaria Latest Developments

Table 122. SYVA Laboratorios Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. SYVA Laboratorios Brucellosis Vaccines Product Offered

Table 124. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 125. SYVA Laboratorios Main Business

Table 126. SYVA Laboratorios Latest Developments

Table 127. Indian Immunologicals Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Indian Immunologicals Brucellosis Vaccines Product Offered

Table 129. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 130. Indian Immunologicals Main Business

Table 131. Indian Immunologicals Latest Developments

Table 132. Qilu Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Qilu Brucellosis Vaccines Product Offered

Table 134. Qilu Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 135. Qilu Main Business

Table 136. Qilu Latest Developments

Table 137. Tecnovax Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. Tecnovax Brucellosis Vaccines Product Offered

Table 139. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 140. Tecnovax Main Business

Table 141. Tecnovax Latest Developments

Table 142. Hester Biosciences Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. Hester Biosciences Brucellosis Vaccines Product Offered

Table 144. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 145. Hester Biosciences Main Business

Table 146. Hester Biosciences Latest Developments

Table 147. Zoetis Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 148. Zoetis Brucellosis Vaccines Product Offered

Table 149. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 150. Zoetis Main Business

Table 151. Zoetis Latest Developments

Table 152. Onderstepoort Biological Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 153. Onderstepoort Biological Brucellosis Vaccines Product Offered

Table 154. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 155. Onderstepoort Biological Main Business

Table 156. Onderstepoort Biological Latest Developments

Table 157. Instituto Rosenbusch Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 158. Instituto Rosenbusch Brucellosis Vaccines Product Offered

Table 159. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 160. Instituto Rosenbusch Main Business

Table 161. Instituto Rosenbusch Latest Developments

Table 162. Ceva Sante Animale Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 163. Ceva Sante Animale Brucellosis Vaccines Product Offered

Table 164. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 165. Ceva Sante Animale Main Business

Table 166. Ceva Sante Animale Latest Developments

Table 167. Calier & Biologicos Laverlam Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 168. Calier & Biologicos Laverlam Brucellosis Vaccines Product Offered

Table 169. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 170. Calier & Biologicos Laverlam Main Business

Table 171. Calier & Biologicos Laverlam Latest Developments

Table 172. Biovet Basic Information, Brucellosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 173. Biovet Brucellosis Vaccines Product Offered

Table 174. Biovet Brucellosis Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 175. Biovet Main Business

Table 176. Biovet Latest Developments

List of Figures

Figure 1. Picture of Brucellosis Vaccines

Figure 2. Brucellosis Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Brucellosis Vaccines Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Brucellosis Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Brucellosis Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of S19 Vaccine

Figure 10. Product Picture of RB51 Vaccine Strain

Figure 11. Global Brucellosis Vaccines Sales Market Share by Type in 2021

Figure 12. Global Brucellosis Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Brucellosis Vaccines Consumed in Cattle

Figure 14. Global Brucellosis Vaccines Market: Cattle (2017-2022) & (M Doses)

Figure 15. Brucellosis Vaccines Consumed in Sheep

Figure 16. Global Brucellosis Vaccines Market: Sheep (2017-2022) & (M Doses)

Figure 17. Brucellosis Vaccines Consumed in Others

Figure 18. Global Brucellosis Vaccines Market: Others (2017-2022) & (M Doses)

Figure 19. Global Brucellosis Vaccines Sales Market Share by Application (2017-2022)

Figure 20. Global Brucellosis Vaccines Revenue Market Share by Application in 2021

Figure 21. Brucellosis Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Brucellosis Vaccines Revenue Market Share by Company in 2021

Figure 23. Global Brucellosis Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Brucellosis Vaccines Revenue Market Share by Geographic Region in 2021

Figure 25. Global Brucellosis Vaccines Sales Market Share by Region (2017-2022)

Figure 26. Global Brucellosis Vaccines Revenue Market Share by Country/Region in 2021

Figure 27. Americas Brucellosis Vaccines Sales 2017-2022 (M Doses)

Figure 28. Americas Brucellosis Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. APAC Brucellosis Vaccines Sales 2017-2022 (M Doses)

Figure 30. APAC Brucellosis Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Europe Brucellosis Vaccines Sales 2017-2022 (M Doses)

Figure 32. Europe Brucellosis Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Brucellosis Vaccines Sales 2017-2022 (M Doses)

Figure 34. Middle East & Africa Brucellosis Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Americas Brucellosis Vaccines Sales Market Share by Country in 2021

Figure 36. Americas Brucellosis Vaccines Revenue Market Share by Country in 2021

Figure 37. United States Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Brucellosis Vaccines Sales Market Share by Region in 2021

Figure 42. APAC Brucellosis Vaccines Revenue Market Share by Regions in 2021

Figure 43. China Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Brucellosis Vaccines Sales Market Share by Country in 2021

Figure 50. Europe Brucellosis Vaccines Revenue Market Share by Country in 2021

Figure 51. Germany Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Brucellosis Vaccines Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Brucellosis Vaccines Revenue Market Share by Country in 2021

Figure 58. Egypt Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Brucellosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Brucellosis Vaccines in 2021

Figure 64. Manufacturing Process Analysis of Brucellosis Vaccines

Figure 65. Industry Chain Structure of Brucellosis Vaccines

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles